CECOG Academy

www.cecog.org

 

CECOG Academy
R

Immune Checkpoint Inhibition in mBC: Does the Chemotherapy Backbone Matter?

By CECOG Academy FEATURING Rupert Bartsch
By CECOG Academy FEATURING Rupert Bartsch
17 views
March 29, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das

Featured Video

18:56
Incyte

The Importance of NGS Testing in iCCA – A Patient Case

Feat. M. Khasawneh
Post ESMO Webinar
11:47

Adjuvant Therapies for HER2+ eBC: Trastuzumab & Pertuzumab, T-DM1 & …

CECOG Academy

C. Singer

66 views
14:05

New Adjuvant Therapies for eBC: Olaparib & Talazoparib for BRCA Muta…

CECOG Academy

C. Singer

115 views
29:38

monarchE vs. PALLAS Data on Adjuvant ET in HR+ EBC: What Makes the C…

CECOG Academy

A. Awada

641 views
22:11

How to Increase the Efficacy of Antiendocrine Treatment of BC: Optio…

CECOG Academy

P. Fasching

57 views
22:31

Immune Checkpoint Inhibition in mBC: Does the Chemotherapy Backbone …

CECOG Academy

R. Bartsch

17 views